New drug ONC-783 enters human testing for advanced cancers
Disease control
Not yet recruiting
This early-phase study tests a new drug called ONC-783 in 20 adults with advanced solid tumors, including colorectal, ovarian, pancreatic, or breast cancer that has spread. The main goal is to find the safest and most effective dose and check for side effects. Participants will r…
Phase: PHASE1 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC